Philippe Bey
Chief Executive Officer at Thrasos, Inc.
Profile
Philippe Bey is currently the Chief Executive Officer at Thrasos, Inc. Prior to this, he held positions such as Chief Scientific Officer at ArQule, Inc., Vice President-Global Research at Marion Merrell Dow, Inc., Senior Vice President-Research & Development at Hoechst Marion Roussel, Inc., President-Research Institute at Merrell Dow Pharmaceuticals, Inc., and Principal at Richardson-Merrell.
He also served as Senior Vice President-Research & Development at Thrasos Therapeutics, Inc. Dr. Bey received his undergraduate and doctorate degrees from the University of Strasbourg.
Philippe Bey active positions
| Companies | Position | Start |
|---|---|---|
Thrasos, Inc.
 Thrasos, Inc. Pharmaceuticals: MajorHealth Technology Thrasos, Inc. discovers and develops drugs. The company develops protein mimetic compounds for Kidney and Heart disease. Thrasos is headquartered in Hopkinton, MA | Chief Executive Officer | - |
Former positions of Philippe Bey
| Companies | Position | End |
|---|---|---|
| Merrell Dow Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| Richardson-Merrell | Corporate Officer/Principal | - |
| Marion Merrell Dow, Inc. | Chief Tech/Sci/R&D Officer | - |
| Hoechst Marion Roussel, Inc. | Chief Tech/Sci/R&D Officer | - |
| ARQULE, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Philippe Bey
| University of Strasbourg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Thrasos, Inc.
Thrasos, Inc. Pharmaceuticals: MajorHealth Technology Thrasos, Inc. discovers and develops drugs. The company develops protein mimetic compounds for Kidney and Heart disease. Thrasos is headquartered in Hopkinton, MA | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
| Merrell Dow Pharmaceuticals, Inc. | |
| Richardson-Merrell | |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
- Stock Market
- Insiders
- Philippe Bey
